Cabaletta Bio

Developer of CAAR T cells for B cell-mediated autoimmune diseases

placeRadnor, Pennsylvania, United States calendar_todayFounded 2017 groups60 employees language cabalettabio.com

Registered entities

Social engagement

Social engagement: 18.4K social following, 8 posts in the last 12 months — above the industry median.

Investor mix

7 investors on record; lead investors include 5AM Ventures, Deerfield, Redmile Group, Cormorant Capital.

Investor typeCountShare
Venture capital229%
Bank & private debt114%
Other / undisclosed457%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

5 Feb 2026 · Supply Chain Coordinator · Philadelphia

Based on job postings tracked across public sources.

Recent activity

14 May 2026
Milestone
revenue
28 Apr 2026
Partnership
Cellares
27 Apr 2026
Event
ASGCT2026 Annual Meeting
Coming soon